3rd Quarter - Report

AVENUE SOLUTIONS for JAZZ PHARMACEUTICALS, INC.

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Drug safety issues; Prescription drug abuse; Monitor drug pricing legislation; H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act; S. 1895, Lower Health Care Costs Act; S. 1416, Affordable Prescriptions for Patients Act of 2019; H.R. 5133, Affordable Prescriptions for Patients Through Promoting Competition Act of 2019; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; Public Law 116-136, CARES Act; H.R. 1425, Patient Protection and Affordable Care Enhancement Act (PPACEA); Issues related to Priority Review Voucher extension; H.R. 6800, The Heroes Act; H.R. 925, The Heroes Act

LobbyistCovered position, as disclosed
TRACY SPICER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6800 (116th), S. 1895 (116th), H.R. 3 (116th), H.R. 5133 (116th), H.R. 925 (116th), S. 1416 (116th), H.R. 987 (116th), H.R. 1425 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.